Hepatitis C treatment: Trial by design

Hepatitis C treatment: Trial by design

Bibliografiske detaljer
Hovedforfatter:	Bzeizi Khalid
Format:	Article
Sprog:	English
Udgivet:	Wolters Kluwer Medknow Publications 2008-01-01
Serier:	The Saudi Journal of Gastroenterology
Online adgang:	http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2008;volume=14;issue=2;spage=51;epage=52;aulast=Bzeizi

Lignende værker

Coincidence of acute <i>Brucella</i> hepatitis and dengue fever or serologic cross-reactivity?
af: Bzeizi Khalid, et al.
Udgivet: (2010-01-01)

Albumin use in cirrhotic patients: The case against
af: Syed Muhammad, et al.
Udgivet: (2007-01-01)

Randomized controlled trial using education material to improve hepatitis C treatment adherence among hepatitis C patients in Tripoli Medical Center
af: Adam, Samia Ibrahim Mohamed, et al.
Udgivet: (2017)

Hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial
af: Mazhar Haque, et al.
Udgivet: (2009-01-01)

Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics
af: Litwin Alain H, et al.
Udgivet: (2011-11-01)

Epidemiology and Treatment of Hepatitis C Genotypes 5 and 6
af: Khalid Al Naamani, et al.
Udgivet: (2013-01-01)

The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Linkage-to-Care Trial: rationale and design of an emergency department-based randomized clinical trial of linkage-to-care strategies for hepatitis C
af: Sarah E. Rowan, et al.
Udgivet: (2023-01-01)

The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Screening Trial: rationale and design of a multi-center pragmatic randomized clinical trial of hepatitis C screening in emergency departments
af: Jason S. Haukoos, et al.
Udgivet: (2022-04-01)

The Evolution of Hepatitis C Treatment
af: Masoomeh Sofian
Udgivet: (2018-10-01)

Design of a multicenter randomized clinical trial for treatment of Alcohol-Associated Hepatitis
af: Wanzhu Tu, et al.
Udgivet: (2023-04-01)

Treatment options to support the elimination of Hepatitis C: an open label, factorial randomised controlled trial
af: Cooke, G, et al.
Udgivet: (2025)

Planning a programme of pre-authorisation clinical trials of medicines for the treatment of chronic hepatitis C
af: A. I. Gubenko, et al.
Udgivet: (2019-03-01)

Development of novel treatments for hepatitis C.
af: Webster, D, et al.
Udgivet: (2009)

Emerging therapies for the treatment of hepatitis C
af: Christian M Lange, et al.
Udgivet: (2013-09-01)

Treatment of hepatitis C in patients with thalassemia
af: Emanuele Angelucci, et al.
Udgivet: (2008-08-01)

Innovations in Hepatitis C Screening and Treatment
af: Arpan A. Patel, et al.
Udgivet: (2021-03-01)

Treatment guidelines for Hepatitis C in Spain
af: M. Crespo-Casal

Takayasu's arteritis and liver transplantation: Association and implications
af: Fahdah Alokaily, et al.
Udgivet: (2015-01-01)

Treatment of chronic hepatitis C in treatment-naïve patients
af: Marcelo Simão Ferreira

2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
Udgivet: (2018-09-01)

Eliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat), a phase IV, single-arm, open-label trial of sofosbuvir/velpatasvir for the treatment of hepatitis C
af: Peter Vickerman, et al.
Udgivet: (2021-07-01)

Predictors of non-adherence of hepatitis C patients to treatment: a systematic review
af: Ibrahim Adam, Samia, et al.
Udgivet: (2017)

Safety and efficacy of limited laboratory monitoring for hepatitis C treatment: a blinded clinical trial in Rwanda
af: Grant, P, et al.
Udgivet: (2020)

Safety and Efficacy of Limited Laboratory Monitoring for Hepatitis C Treatment: A Blinded Clinical Trial in Rwanda
af: Philip Grant, et al.
Udgivet: (2020-04-01)

Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)
af: Marina V. Mayevskaya, et al.
Udgivet: (2018-08-01)

Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B
af: Faisal M. Sanai, et al.
Udgivet: (2017-08-01)

Industry’s role in HIV, hepatitis B, and hepatitis C exclusion in AML and MDS clinical trials
af: Tahsin Anwar, et al.
Udgivet: (2023-12-01)

New drugs in the treatment of chronic hepatitis C
af: R. Jimenez Galan, et al.
Udgivet: (2014-04-01)

Treatment approach in chronic hepatitis C infection
af: Aslıhan Ulu, et al.
Udgivet: (2016-06-01)

Treatment approach in chronic hepatitis C infection
af: Suheyla Komur, et al.
Udgivet: (2016-06-01)

Hyperpigmentation of Tongue Associated with Hepatitis C Treatment
af: Aşkın Erdoğan, et al.
Udgivet: (2013-06-01)

Viral hepatitis B and C. Cure or treatment?
af: Dimitrios A. Kountouras
Udgivet: (2014-12-01)

Hepatitis C Treatment: A Review and Update
af: Jelena Jakab, et al.
Udgivet: (2017-04-01)

Hepatitis C treatment: where are we now?
af: Burstow NJ, et al.
Udgivet: (2017-02-01)

Hepatitis C Treatment: current and future perspectives
af: Akram Madiha, et al.
Udgivet: (2010-11-01)

Strategies for hepatitis C virus treatment failure
af: Shang-Chin Huang, et al.
Udgivet: (2022-05-01)

Prospects for current hepatitis C treatment failures
af: Vicente Soriano
Udgivet: (2016-05-01)

Predictors of response to chronic hepatitis C treatment
af: Henrique Sergio Moraes Coelho, et al.
Udgivet: (2010-01-01)

Hepatitis C diagnostics and treatment guidelines in adults
af: V. T. Ivashkin, et al.
Udgivet: (2013-05-01)

Modern modes of chronic hepatitis C treatment
af: V. T. Ivashkin, et al.
Udgivet: (2012-02-01)